<p>In part 1 of this 4-part series, Dr Paul Mather from the Perelman School of Medicine talks about how to select and manage patients with end-stage heart failure.</p>
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the differences between progressive and relapsing multiple sclerosis.
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the differences between progressive and relapsing multiple sclerosis.
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the differences between progressive and relapsing multiple sclerosis.
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the differences between progressive and relapsing multiple sclerosis.
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the different diagnosis tools for multiple sclerosis, as well as challenges in diagnosis.
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the different diagnosis tools for multiple sclerosis, as well as challenges in diagnosis.
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the different diagnosis tools for multiple sclerosis, as well as challenges in diagnosis.
Bardia Nourbakhsh, MD, from Johns Hopkins University School of Medicine discusses the different diagnosis tools for multiple sclerosis, as well as challenges in diagnosis.
Dr Hyman Scott from the UCSF-Glastone Center for AIDS Research discusses pre-exposure prophylaxis (PrEP) therapy, its indications, and clinical data surrounding its use.
